GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Synmosa Biopharma 4114.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

27.85

+2.39%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 6.19bn

FY2016FY2025

Net income

TWD 821.8m

FY2016FY2025

Free cash flow

TWD 130.4m

FY2016FY2025

Shareholders' equity

TWD 8.76bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 6.19bnTWD 5.55bnTWD 5.14bnTWD 4.39bnTWD 3.23bnTWD 3.04bnTWD 2.68bnTWD 2.36bnTWD 1.86bnTWD 1.87bn
Gross profitTWD 2.68bnTWD 2.74bnTWD 2.46bnTWD 1.83bnTWD 1.59bnTWD 1.44bnTWD 1.16bnTWD 1.10bnTWD 718.3mTWD 814.8m
Research and developmentTWD 342.7mTWD 259.7mTWD 210.9mTWD 215.3mTWD 214.4mTWD 159.5mTWD 211.7mTWD 183.7mTWD 187.7mTWD 146.4m
Operating incomeTWD 841.9mTWD 739.1mTWD 620.3m—TWD 185.2mTWD 149.5m−TWD 106.2m−TWD 61.1m−TWD 115.9m−TWD 50.3m
Net incomeTWD 821.8mTWD 684.7mTWD 594.8mTWD 799.1mTWD 303.9mTWD 638.1mTWD 47.1mTWD 430.9mTWD 4.7mTWD 166.7m
Diluted earnings per share1.601.611.402.441.022.390.191.890.020.45

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 13.99bnTWD 12.30bnTWD 11.73bnTWD 11.20bnTWD 10.32bnTWD 10.38bnTWD 8.73bnTWD 7.54bnTWD 7.50bnTWD 6.79bn
Cash and short-term investments——TWD 1.65bnTWD 1.42bnTWD 993.1mTWD 745.4m————
Total liabilitiesTWD 3.89bnTWD 3.91bnTWD 3.63bnTWD 4.55bnTWD 4.22bnTWD 4.42bnTWD 3.92bnTWD 3.06bnTWD 3.54bnTWD 2.44bn
DebtTWD 1.54bnTWD 2.55bnTWD 2.43bnTWD 3.36bnTWD 3.46bnTWD 3.70bnTWD 3.22bnTWD 2.41bnTWD 2.53bnTWD 1.76bn
Shareholders' equityTWD 8.76bnTWD 7.21bnTWD 6.71bnTWD 5.31bnTWD 4.71bnTWD 4.50bnTWD 3.48bnTWD 3.22bnTWD 2.86bnTWD 3.04bn
Shares outstanding514m424m424m327m297m267m248m228m241m369m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 411.6mTWD 780.6mTWD 511.9mTWD 630.2mTWD 444.3mTWD 254.4m−TWD 44.9mTWD 16.0m−TWD 5.2mTWD 236.5m
Capital spending−TWD 281.1m−TWD 269.7m−TWD 269.8m−TWD 129.3m−TWD 93.1m−TWD 154.4m−TWD 183.4m−TWD 314.4m−TWD 146.9m−TWD 423.9m
Free cash flowTWD 130.4mTWD 511.0mTWD 242.2mTWD 501.0mTWD 351.2mTWD 100.0m−TWD 228.3m−TWD 298.4m−TWD 152.1m−TWD 187.4m
Dividends paid−TWD 272.6m−TWD 228.7m−TWD 194.4m−TWD 148.6m−TWD 80.0m−TWD 45.7m−TWD 38.0m−TWD 35.6m−TWD 32.1m−TWD 25.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.92bnTWD 1.63bnTWD 1.59bnTWD 1.54bnTWD 1.61bnTWD 1.45bnTWD 1.51bnTWD 1.42bn
Gross profitTWD 745.0mTWD 689.0mTWD 670.5mTWD 645.7mTWD 723.5mTWD 639.0mTWD 643.6mTWD 612.9m
Operating incomeTWD 260.2m———TWD 265.5mTWD 204.7mTWD 187.5mTWD 188.4m
Net incomeTWD 238.6mTWD 191.8mTWD 189.2mTWD 207.6mTWD 218.1mTWD 207.0mTWD 137.3mTWD 163.4m
Diluted earnings per share0.470.380.370.410.430.380.320.39
Cash from operations−TWD 78.0mTWD 269.0mTWD 185.0mTWD 7.0m−TWD 8.0mTWD 227.0mTWD 247.0mTWD 244.0m
Capital spending−TWD 154.0m−TWD 52.0m−TWD 59.0m−TWD 57.0m−TWD 47.0m−TWD 117.0m−TWD 44.0m−TWD 61.0m
Free cash flow−TWD 232.0mTWD 217.0mTWD 126.0m−TWD 50.0m−TWD 55.0mTWD 110.0mTWD 203.0mTWD 183.0m
Total assetsTWD 15.28bnTWD 14.04bnTWD 13.99bnTWD 14.07bnTWD 14.06bnTWD 13.69bnTWD 12.30bnTWD 12.18bn
DebtTWD 1.78bnTWD 1.40bnTWD 1.54bnTWD 1.64bnTWD 1.68bnTWD 1.72bnTWD 1.73bnTWD 1.69bn
Shareholders' equityTWD 8.65bnTWD 8.80bnTWD 8.76bnTWD 8.65bnTWD 8.40bnTWD 8.19bnTWD 7.21bnTWD 7.08bn

Financial ratios

Data as of 29 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin43.3%49.4%47.9%41.6%49.1%47.2%—
Operating margin13.6%13.3%12.1%17.8%5.7%4.9%—
Net margin13.3%12.3%11.6%18.2%9.4%21.0%—
Return on equity9.4%9.5%8.9%15.0%6.5%14.2%—
Return on assets5.9%5.6%5.1%7.1%2.9%6.1%—
Free cash flow yield—8.5%6.3%7.9%6.2%5.2%1.9%
Revenue growth11.5%8.0%17.2%35.6%6.5%13.4%—
Earnings growth20.0%15.1%-25.6%163.0%-52.4%1255.1%—
Current ratio2.95x2.42x2.14x1.73x1.64x1.91x—
Debt to equity0.18x0.24x0.35x0.63x0.73x0.82x—
Equity ratio62.7%58.6%57.2%47.4%45.6%43.4%—
Interest coverage13.57x12.72x9.22x13.09x3.56x2.83x—
R&D as a share of sales5.5%4.7%4.1%4.9%6.6%5.3%—
Buybacks as a share of market value—0.0%-29.6%-10.0%-11.2%-7.8%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.2%15.3%13.3%
Operating income—41.3%48.0%
Net income0.9%5.2%38.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin46.2%45.7%46.2%45.5%
Operating margin13.5%———
Net margin12.8%13.6%14.0%11.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings18.817.921.013.814.56.066.66.8—25.4
Price to sales2.52.22.42.51.41.31.21.21.42.3

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 17 Jul 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year0.8480.590.5340.4510.372
  • 1101443-for-1000000 split · 11 Jul 2025
  • 1099.8486-for-1000 split · 10 Jul 2025
  • 1101600-for-1000000 split · 9 Aug 2024
  • 1093310.5-for-1000000 split · 8 Aug 2023
  • 1101.3506-for-1000 split · 11 Jul 2022
  • 1120.898-for-1000 split · 23 Sept 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.